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Introduction
F ollowing the seminal work of Murray and Lopez
1 in esti-
mating  the burden of disease (BOD) attributable to ten 
major risk factors in global and regional scales using com-
parative risk assessment (CRA) methodology, subsequent studies 
with the same framework came through.2–5 While these studies are 
interesting and useful for developing future global and regional 
health improvement strategies, due to some important limitations 
they may not be fully applicable for national and sub-national 
scales as policy support. First, only the major risk factors have 
been selected that either their exposure distributions are available 
or feasible to estimate. Meanwhile, the high-priority risk factors to 
be studied in national or sub-national scales may differ based on 
local concerns and situations. In addition, the reference popula-
tion that will be used for standardizations in the national or sub-
national analyses will be also different. Ultimately, the broad esti-
mated global patterns may have masked or underestimated signif-
icant sub-national variations in risks.
Environmental risk factors play an important role in the burden 
of disease both globally and nationally.5–7 In fact, one in four child 
deaths have been caused by unsafe and unhealthy environment, 
worldwide.8 According to the global health risk assessment by 
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World Health Organization (WHO) climate change, indoor smoke 
from solid fuels, lead exposure, urban outdoor air pollution, and 
unsafe water/sanitation/and hygiene cause approximately 10 % of 
deaths and diseases burden and 25 % of disability-adjusted life 
\HDUV'$/<VLQFKLOGUHQXQGHU¿YH\HDUVROG8 Global Burden 
of Disease (GBD) study also showed that from the ten leading risk 
factors in 2010 (ranked by attributable burden of death) two were 
environmental including household air pollution from solid fuels 
(ranked four) and ambient particulate matter pollution (ranked 
seven) (see the heat map from the permanent online link).9 For 
Iran, similarly of the ten leading risk factors in 2010 (again ranked 
by attributable burden of death), two were environmental risk fac-
tors. However, as Iran has large natural gas reservoirs, majority 
of people use gas for cooking and heating; therefore, household 
air pollution from solid fuels was not among the top ten risk fac-
WRUV²UDQNHGLQGHHG,QRWKHUZRUGVDPELHQWSDUWLFXODWHPDW-
ter pollution (ranked six) and lead exposure (ranked ten) were the 
leading environmental risk factors in Iran, 2010 (see the heat map 
from the permanent online link).10 Generally, the proportion of 
ischemic heart disease (IHD) DALYs attributable to ambient par-
ticulate matter pollution, household air pollution from solid fuels, 
and lead exposure in 2010 was estimated to be 22 %, 18 %, and 
4 %, respectively.5 Fine particulate matter was also estimated to 
cause roughly 8 %, 5 %, and 3 % of lung cancer, cardiopulmo-
nary deaths, and respiratory infection deaths, respectively.8 Of the 
environmental risk factors, climate change also has a substantial 
impact on the burden of disease. It has been estimated that be-
tween 1990 and 2100, the global average temperature rises by 1.1 
to 6.4 °C.11 Nonetheless, CRA study of climate change indices, 
VXFKDVLQFUHDVHGWHPSHUDWXUHVRUÀRRGVLVFKDOOHQJLQJDVWKHUHLV
considerable complexity and uncertainty in models of attributable 
avoidable impacts (i.e. establishing a counterfactual scenario).8
As mentioned above, GBD studies have some uncertainties 
in their estimates. In fact, conducting national and sub-national 
BOD studies may better account indeterminacies and provide an 
opportunity to reassess GBD estimates.  In order to develop effec-
tive policy measures, quantitative information about the extent of 
health impacts of different environmental stressors is needed. In 
this paper, we will introduce and discuss the general framework 
of the Environmental Burden of Disease (EBD) study in Iran, 
which is part of the National and Sub-national Burden of Disease 
study, with updated exposure estimates, updated effect sizes for 
risks, and more number of risk factors related to national and sub-
QDWLRQDOFRQFHUQV7KH¿UVWDLPRI(%'LVWRHVWLPDWHH[SRVXUH
distribution of selected major environmental risk factors among 
the entire Iranian population from 1990 to 2013. The second aim 
is to estimate the burden of disease attributable to these risks using 
the following metrics: prevalence, death, years of life lost due to pre-
mature death (YLL), years of life lost due to disability (YLD), and 
DALYs. Finally, special focus will be placed on assessing national 
and sub-national inequalities of environmental risk factors.
Materials and Methods
Executive study phases
In order to design the study framework of EBD, an expert panel 
was formed consisting of six environmental health experts, three 
epidemiologists, and one biostatistician. According to a risk-based 
approach, the EBD expert panel listed the major environmental 
determinants of health (i.e. risk factors) from the full list of the 
GBD risk factors and other similar projects through comprehen-
sive reviews of published works and numerous meetings. How-
HYHUWKLVOLVWZDV¿QDOL]HGEDVHGRQ,UDQ¶VVLWXDWLRQDQGSULRULWLHV
Next, since it was not feasible to include all major risk factors in 
WKH(%'VWXG\DQRYHOMXVWL¿DEOHSURWRFROFRPSULVLQJWZRVWHSV
was developed by the expert panel to select the high-priority risk 
IDFWRUV7KH¿UVWVWHSZDVVFRULQJWKHIRXUSULPDU\FULWHULDLH
public health impact, high individual risk, high political or public 
FRQFHUQDQGHFRQRPLFVLJQL¿FDQFHLQWURGXFHGE\WKH(XURSHDQ
Burden of Disease study6IURPWR²WKLVVFRUHZDVXVHGDVD
weighting factor for the second step. In the second step, the four 
criteria were scored from 0 (low importance) to 10 (high impor-
tance) for each risk factor. Thereafter, they were multiplied by the 
ZHLJKWJLYHQLQWKH¿UVWVWHS)LQDOO\WKHVFRUHVRIHDFKULVNIDFWRU
were summed and ranked to select the high-priority risk factors. 
The members of the internal EBD expert panel and those of the 
external EBD advisory board, who are introduced at the end of 
WKLVDUWLFOHIXO¿OOHGWKHVFRULQJ7KHKLJKSULRULW\ULVNIDFWRUVXO-
timately, were selected based on the mentioned protocol. In addi-
tion, a technical team was then formed for each risk factor. 
The selected high-priority risk factors (based on the developed 
protocol after scoring) were Particulate Matter with an aerody-
QDPLF GLDPHWHU RI   PLFURPHWHUV 302.5), Tropospheric 
Ozone (O3), Benzene, Second-hand Smoke, Ultraviolet Radiation 
(UV), Environmental Noise, Indoor Radon, Unsafe Water/Sanita-
tion/and Hygiene, Drinking Water Fluoride, Dioxins and Furans, 
Climate Change Indices, and Sulfur Dioxide (SO2), (Table 1). 
Noteworthy, we also took into account two more criteria for se-
OHFWLQJWKHULVNIDFWRUV7KH¿UVWZDVWKHDFFHVVLELOLW\RIULVNIDF-
tors’ data/proxy covariates or feasibility to access them; the other 
was the availability of evidence-based dose-response functions 
derived from WHO guidelines, meta-analyses, and/or credible 
FXUUHQW VFLHQWL¿F OLWHUDWXUH LQFOXGLQJ LQGLYLGXDO VWXGLHV)LQDOO\
each technical team drafted a proposal for their target risk factor, 
ZKLFKZDVHYDOXDWHGDQGFRQ¿UPHGE\WKH(%'H[SHUWSDQHODQG
the NASBOD core team.
Research objectives
I. National and sub-national exposure trends
y Determining national and sub-national trends of exposure 
to PM2.5, O3, Benzene, Second-hand Smoke, UV, Environmen-
tal Noise, Indoor Radon, Unsafe Water/Sanitation/and Hygiene, 
Drinking Water Fluoride, Dioxins and Furans, Climate Change, 
and SO2 from 1990 to 2013
II. National and sub-national Burden of Disease
y Calculating national and sub-national Burden of Disease at-
tributable to the above mentioned risk factors from 1990 to 2013.
III. National and sub-national inequality and its determinants assess-
ment
y Determining national and sub-national inequalities in the ex-
posure distribution of the above mentioned risk factors from 1990 
to 2013.
Data sources
The information about the level of exposure to the risk factors, 
health endpoints, and the RRs of each outcome attributable to an 
environmental risk factor will be collected from: a) data published 
in peer reviewed papers through a systematic review and meta-
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analysis (if necessary); b) data from national or sub-national sur-
veys, which partly have been collected by the Center for Environ-
mental and Occupational Health of Ministry of Health and Medi-
cal Education (CEOH-MOHME) and Institute for Environmental 
Research (IER), available via National Comprehensive System of 
Environmental Health Information;12 and c) other sources, such as 
data collected by government organizations or by Department of 
Environment (DOE), or unpublished international, national, and 
sub-national data. Details of each source(s) are described below.
I. Systematic review
In order to collect exposure data from 1990 to 2013, a system-
atic review will be conducted following the requirement and deci-
sion of technical teams for each risk factor to compile all relevant 
data. In other words, systematic reviews and meta-analyses will 
be conducted to obtain RRs of each risk factor attributable to the 
outcomes, if needed. Meanwhile, if there are credible and reliable 
recently published systematic reviews and/or meta-analyses, the 
technical teams may decide to use their results.
Search strategy
Systematic reviews will be conducted mainly through the avail-
able online national and international databases and indexing 
VHUYLFHV7KHQDWLRQDOWDUJHWGDWDEDVHVDUH6FLHQWL¿F,QIRUPDWLRQ
Database (SID), IranMedex, and Irandoc. SID is the largest up-
to-date Iranian data bank, started in 2004. This database makes 
it possible to search amongst more than 130,000 and 200,000 
Persian and English Iranian articles, respectively. IranMedex con-
tains over 70,000 Iranian articles from about 228 medical/health 
oriented journals. Irandoc, also, covers more than 120,000 Iranian 
theses, 15,000 theses of Iranian students who have been graduated 
in foreign universities, 90,000 research projects, 140,000 Persian 
articles, 28,000 governmental reports, and 106,000 presented ar-
WLFOHVLQVFLHQWL¿FFRQJUHVVHV7KHLQWHUQDWLRQDOGDWDEDVHVDUH:HE
RI6FLHQFH3XE0HGDQG6FRSXV7R¿QGDOO UHOHYDQWGDWDDQG
LQIRUPDWLRQWKHWHFKQLFDOWHDPVZLOOGH¿QHDGHWDLOHGVHDUFKVWUDW-
egy based on Medical Subject Headings (MeSH),13 Emtree (the 
Embase thesaurus), and/or other pertaining keywords for each risk 
factor. The other sources of systematic reviews are: a) abstracts 
and proceedings of national and international conferences; b) PhD 
or DSc dissertations and MD, MPH, MSc, or MSPH theses within 
national relevant departments; c) accepted manuscripts which are 
published online and are available through some publications; and 
¿QDOO\GFRPSOHPHQWDU\GDWDREWDLQHGIURPUHVHDUFKHUVWKURXJK
contacting the author.
Selection criteria and variables
For international data sources, studies published over 1990 to 
2013 will be selected, while for national data sources, those pub-
lished in the corresponding national calendar year will be includ-
HG(DFKWHFKQLFDOWHDPLVIUHHWRGH¿QHRWKHUVHOHFWLRQFULWHULD
The major variables are exposure levels, sample size of studies, 
health related endpoints, effect size, standard deviation (SD), and 
FRQ¿GHQFHLQWHUYDO&,RUVWDQGDUGHUURU6(RIWKHHIIHFWIRUWKH
mentioned risk factors and outcomes.
Quality assessment of the articles
In order to assess the quality of the source(s), two reviewers 
within each technical team will independently evaluate them and 
conclude whether they qualify to be involved in the study using 
critical appraisal instruments. Finally, an expert or the head of 
HDFK WHFKQLFDO WHDP FRQWUROV DQG FRQ¿UPV UHYLHZHUV¶ GHFLVLRQ
DERXWLQYROYLQJWKHFROOHFWHGVRXUFHVEDVHGRQWKHGH¿QHGVHOHF-
tion criteria. If there is a disagreement between the reviewers, the 
WKLUGUHYLHZHUZLOO¿QDOL]HWKHGHFLVLRQ1RWHZRUWK\HDFKWHFKQL-
cal team is free to assess the methodology quality of the sources.
II. Other sources
Several databases have measured or estimated the required data, 
namely CEOH-MOHME, DOE, and Global Burden of Disease 
(GBD) 2010. So far, we have acquired the data about globally 
estimated PM2.5 and O3 risk factors in 1990, 2005, and 2010 from 
the corresponding author of that study, and we have obtained per-
mission to use them for EBD-NASBOD study.14–15
Statistical methods and analysis plans
Within the context of our extensive research to access all national 
and sub-national data, some provinces are expected to lack envi-
ronmental risk factors exposure data. Additionally, many surveys 
do not include all age groups, both sexes, and rural/urban areas 
of residence. Therefore, two distinct statistical models, i.e. spa-
tiotemporal and Bayesian autoregressive multilevel models,16–17 
were developed to estimate mean (whatever the measure is) and 
its uncertainty interval for each sex, age, year, and province of 
UHVLGHQFH7KHPRGHOVZLOOHPSOR\GDWDRIDVSHFL¿FDJH\HDU
and province along with data from other ages, other years, and 
other provinces. There exists the issue of misaligned areal units 
for the provinces separated in the desired period, which will be 
tackled in both models. We are using two models to verify that the 
results are not model-dependent.
Spatiotemporal model
We should take into consideration the temporal and spatial cor-
relations, because the majority of environmental exposure data, 
such as air pollution, noise, etc., will be collected across time 
and space. One of the conventional frameworks for this type of 
data is spatiotemporal Bayesian hierarchical modeling with con-
ditional autoregressive prior for spatial random effects.16 In the 
spatial framework, it is assumed that the observations closer in 
space are more correlated than those far in space. Therefore, us-
ing this framework, the model is permitted to borrow informa-
tion from neighboring areal units, which improves the estimates 
for areas with missing values and/or those with small number of 
observations. In addition, in order to combine incompatible areal 
units between data sources and/or over the years, spatiotemporal 
misalignment modeling will be used, which includes covariates 
effects, non-linear age trend, and study quality and source of data 
variations. Finally, this model can arbitrarily accommodate the 
missing data.
Bayesian Autoregressive Multilevel model
Another advanced method to handle the challenges mentioned 
earlier is the Bayesian Autoregressive Multilevel model.17 This 
framework nests observations hierarchically in districts, prov-
inces, sub-regions, regions, and national levels, respectively. In 
addition, in this hierarchical model, lower levels borrow informa-
tion from higher levels; furthermore, depending on the degree 
of data availability, units of each level lend information to each 
other. Several components, such as linear time trends, nonlinear 
change over time, covariate effects, nonlinearity associated with 
Archives of Iranian Medicine, Volume 17, Number 1, January 2014 67
+$PLQL06KDPVLSRXU0+6RZODWHWDO
age, heterogeneity of data sources, and age-by-study variability, 
are included in this model. To offer a natural solution to the men-
tioned problems, Bayesian autoregressive multilevel model merg-
es information from several data sources and also from available 
prior information. If necessary, estimates will be obtained using 
time-varying district-level or province-level covariates.
For both of the abovementioned modeling frameworks, we will 
use the Markov Chain Monte Carlo (MCMC) method to perform 
Bayesian inference, due mainly to its general applicability and 
ease of implementation. All of the programs will be developed in 
R statistical packages.18
In addition to these challenges, another problem is related to the 
VXPPDU\ VWDWLVWLFV UHSRUWHG ZLWK GLIIHUHQW FODVVL¿FDWLRQV 7KLV
problem will be tackled by cross walking between continuous and 
categorical measures of the target variables.
Ethical considerations
6LQFHWKHSUHVHQWZRUNLVDVHFRQGDU\VWXG\WKHUHDUHQRVSHFL¿F
ethical considerations. However, the publication of the results will 
depend on the permission of the study funders. Likewise, Tehran 
University of Medical Sciences’ Institutional Review Board ap-
proved this study for ethical considerations.
Discussion
7KLVLVWKH¿UVWVWXG\RQWKHEXUGHQRIGLVHDVHDWWULEXWDEOHWRWKH
major environmental risk factors in Iran using a comparative risk 
assessment framework. Generally, there are a number of studies 
that have assessed burden of disease in national or sub-national 
scales from Australia,19–22 Ghana,23 India,24 Iran,25–26 Japan,27 Ke-
nya,28 Mexico,29–30 Nairobi,31 Netherlands,32–33 New Zealand,34 
Pakistan,35 South Africa,36–37 Thailand,38 UK,39 USA,40–41 and Viet-
nam.42 Of these, several have included burden of disease attribut-
able to environmental risk factors. In brief, Begg and colleagues 
(2008) have assessed burden of disease attributable to outdoor air 
pollution in Australia in 2003. Indeed, they have found that 0.8 % 
of Australian’s health loss (DALYs per 1000 people) due to can-
cers and 2.7 % due to cardiovascular diseases were attributable 
to outdoor air pollution.19 Smith (2000) also reported burden of 
disease attributable to indoor air pollution from solid fuels in In-
dia. In fact, it has been estimated that, roughly 400 – 500 thousand 
premature deaths annually within subgroups of adult males and 
children fewer than 5 years old are attributable to indoor air pol-
lution from solid fuels. Consequently, indoor air pollution causes 
about 4 % – 6 % of total DALYs in India. Smith also reported that 
approximately 9.6 to 14 million DALYs due to acute respiratory 
infection, 0.39 to 0.68 million DALYs due to chronic obstructive 
pulmonary diseases, 0.004 to 0.009 million DALYs due to lung 
cancer, 0.064 to 0.13 million DALYs due to blindness, and 0.27 
to 0.68 million DALYs due to asthma are attributable to indoor air 
pollution from solid fuels.24 Noteworthy, as Iran has large natural 
gas reservoirs, this risk factor has much less contribution in the 
EXUGHQRIGLVHDVHQDWLRQZLGH²LW LV UDQNHG LQ*%'43 
Overall, the burden of disease in India due to indoor air pollution, 
which is estimated to be 5.9 % – 9.2 % of total India’s BOD, is 
nearly rivaling poor water, sanitation, and hygiene risk factors.24 
Snow, et al. (1998) also estimated burden of malaria in Kenya and 
reported that each day approximately 72 – 400 children younger 
than 5 years old die or develop clinical stages of malaria.28 In 
Mexico, Stevens and colleagues (2008) assessed burden of dis-
ease due to unsafe water/sanitation/and hygiene, urban and indoor 
air pollution and found that 1.6 % of total deaths have occurred 
due to urban air pollution in 2004.30 The long-term effects of par-
ticulate air pollution, in Netherlands, have been estimated to cause 
60 % of the total environment-related health loss. Besides, envi-
ronmental noise and indoor air pollution (including second-hand 
smoke, humidity, radon, as well as drinking water lead) have been 
estimated to cause about 4 % and 6 % of total health loss, respec-
tively. Overall, less than 5 % of total annual burden of disease 
in Netherlands was attributable to the studied environmental risk 
factors.32 Additionally, Hänninen and Knol (2011) reported that 3 
% – 7 % of the burden of disease in six European countries (Bel-
gium, Finland, France, Germany, Italy, and the Netherlands) is 
associated with nine environmental risk factors (PM2.5, benzene, 
dioxin and furans, non-smokers exposure to second-hand smoke, 
formaldehyde, lead, transportation noise, ozone, and radon).6
To our best knowledge, some of the selected environmental risk 
factors in Iran, including O3, UV Radiation, Drinking Water Fluo-
ride, Climate Change indices and SO2 have not yet been studied at 
sub-national levels for their burden of disease using a comparative 
risk assessment framework. To select these risk factors, we have 
developed a novel approach, which is described above. Notably, 
albeit based on GBD 2010 study lead exposure ranked 10 out 
of 20 among Iran’s leading risk factors, based on our developed 
protocol it was not chosen to be studied in EBD-NASBOD 1990 
– 2013 study. This is mainly due to the importance of other un-
studied risk factors in the GBD based on the developed protocol 
and national priorities.
(PSLULFDOVFLHQWL¿FHYLGHQFHRQWKHEXUGHQRIGLVHDVHDWWULEXW-
able to the major risk factors and health status of general popula-
tion in national or local scales provide a crucial baseline for policy 
support. Results of EBD study may underscore priority risk fac-
tors to be tackled in national or sub-national levels. Meanwhile, 
one of the most important achievements of the EBD study is that 
GXULQJWKHSURJUHVVLRQRIWKHVWXG\ÀDZVRIWKHQDWLRQDOKHDOWK
LQIRUPDWLRQV\VWHPZLOOEHGHWHFWHG,QRWKHUZRUGVZHZLOO¿QG
out which risk factors and their health endpoints and how, espe-
cially in a sub-national scale, should be measured or registered. 
Finally, we will provide recommendations to improve the national 
and sub-national health information system. In order to attain the 
mentioned objectives, especially improving the national health 
information system, at the end of the study, the EBD and NAS-
BOD contributors will be able to disseminate their knowledge to 
the whole country levels through presenting workshops, sympo-
siums, and so forth. 
The EBD study has some limitations. First, there might be prob-
lems regarding missing data, especially for sub-national levels. 
We will try to impute missing data using statistical methods, or 
using proxy covariates and extrapolating to each district-year. In 
the absence of reliable evidence for etiological effects from Iran, 
large meta-analyses of regional or international cohorts are the 
best sources of etiological effect sizes but transportability of ef-
fects from one population to another may be a weak assumption 
and depends on similarity of populations with regard to effect 
PRGL¿HUDQGYHUVLRQRIH[SRVXUHV
The EBD will try to determine burden of disease attributable to 
major environmental risk factors. This achievement will help to 
broaden our knowledge about the most important risk factors in 
Iran. We will also determine national and sub-national inequalities 
in exposure distribution of the selected risk factors and their deter-
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minants. This will guide national and sub-national policy makers 
to invest more on priority risk factors and intervene effectively 
through cost-effective measures.
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